A Prospective Longitudinal Study to Identify Biomarkers in Children With Hemangiomas
NCT ID: NCT01598116
Last Updated: 2021-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
68 participants
OBSERVATIONAL
2010-12-12
2017-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities
NCT02061735
Optical Tomographic Imaging of Infantile Hemangiomas
NCT01673971
Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas
NCT00374335
Pediatric Catheter-related Thrombosis Imaging Study
NCT01137578
Ultrasonographic Prognostic Scale of Periventricular Hemorrhagic Infarction
NCT05918016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemangioma
Identify biomarkers in children with hemangiomas.
Urine collection and ultrasonography
Bagged urine collection and ultrasound at each visit
Without Hemangioma
Age-matched controlled group without hemangioma.
Urine collection
Bagged urine collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urine collection and ultrasonography
Bagged urine collection and ultrasound at each visit
Urine collection
Bagged urine collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≤ 5 months
* Doppler ultrasound confirmed diagnosis of hemangioma to rule out presence of vascular malformation
* Age matched control ≤ 5 months (no hemangioma)
Exclusion Criteria
* Known history of sickle cell anemia, thalassemia, or other hemoglobinopathy
* Hemangioma presented as fully formed at birth consistent with rapidly involuting or non-involuting congenital hemangioma
* PHACES syndrome- posterior fossa malformations, hemangioma, arterial anomalies, cardiac anomalies, eye abnormalities, sternal anomalies
* Parent/guardian unable to speak english to provide informed consent and no interpreter is present
4 Weeks
5 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nationwide Children's Hospital
OTHER
Gayle Gordillo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gayle Gordillo
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gayle M Gordillo, MD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nationwide Children's Hospital
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-00482
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.